Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

333 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Germinal Center Dark Zone harbors ATR-dependent determinants of T-cell exclusion that are also identified in aggressive lymphoma.
Cancila V, Morello G, Bertolazzi G, Chan AS, Bastianello G, Paysan D, Jaynes PW, Schiavoni G, Mattei F, Piconese S, Revuelta MV, Noto F, De Ninno A, Cammarata I, Pagni F, Venkatachalapathy S, Sangaletti S, Di Napoli A, Vacca D, Lonardi S, Lorenzi L, Ferreri AJM, Belmonte B, Varano G, Colombo MP, Bicciato S, Inghirami G, Cerchietti L, Ponzoni M, Zappasodi R, Facchetti F, Foiani M, Casola S, Jeyasekharan AD, Tripodo C. Cancila V, et al. Among authors: inghirami g. Res Sq [Preprint]. 2024 Mar 18:rs.3.rs-4093618. doi: 10.21203/rs.3.rs-4093618/v1. Res Sq. 2024. PMID: 38562878 Free PMC article. Preprint.
Anaplastic lymphoma kinase in human cancer.
Barreca A, Lasorsa E, Riera L, Machiorlatti R, Piva R, Ponzoni M, Kwee I, Bertoni F, Piccaluga PP, Pileri SA, Inghirami G; European T-Cell Lymphoma Study Group. Barreca A, et al. Among authors: inghirami g. J Mol Endocrinol. 2011 Jul 4;47(1):R11-23. doi: 10.1530/JME-11-0004. Print 2011 Aug. J Mol Endocrinol. 2011. PMID: 21502284 Review.
Targeting CD25+ lymphoma cells with the antibody-drug conjugate camidanlumab tesirine as a single agent or in combination with targeted agents.
Spriano F, Tarantelli C, Cascione L, Gaudio E, Golino G, Scalise L, Cacciapuoti MT, Zucca E, Stathis A, Van Berkel PH, Inghirami G, Zammarchi F, Bertoni F. Spriano F, et al. Among authors: inghirami g. Br J Haematol. 2024 Nov;205(5):1873-1882. doi: 10.1111/bjh.19658. Epub 2024 Jul 30. Br J Haematol. 2024. PMID: 39080847
3D chromatin hubs as regulatory units of identity and survival in human acute leukemia.
Gambi G, Boccalatte F, Rodriguez Hernaez J, Lin Z, Nadorp B, Polyzos A, Tan J, Avrampou K, Inghirami G, Kentsis A, Apostolou E, Aifantis I, Tsirigos A. Gambi G, et al. Among authors: inghirami g. Mol Cell. 2025 Jan 2;85(1):42-60.e7. doi: 10.1016/j.molcel.2024.11.040. Epub 2024 Dec 23. Mol Cell. 2025. PMID: 39719705
Mutability and hypermutation antagonize immunoglobulin codon optimality.
McGrath JJC, Park J, Troxell CA, Chervin JC, Li L, Kent JR, Changrob S, Fu Y, Huang M, Zheng NY, Wilbanks GD, Nelson SA, Sun J, Inghirami G, Madariaga MLL, Georgiou G, Wilson PC. McGrath JJC, et al. Among authors: inghirami g. Mol Cell. 2024 Dec 12:S1097-2765(24)00988-2. doi: 10.1016/j.molcel.2024.11.033. Online ahead of print. Mol Cell. 2024. PMID: 39708804
EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell function.
Isshiki Y, Chen X, Teater M, Karagiannidis I, Nam H, Cai W, Meydan C, Xia M, Shen H, Gutierrez J, Easwar Kumar V, Carrasco SE, Ouseph MM, Yamshon S, Martin P, Griess O, Shema E, Porazzi P, Ruella M, Brentjens RJ, Inghirami G, Zappasodi R, Chadburn A, Melnick AM, Béguelin W. Isshiki Y, et al. Among authors: inghirami g. Cancer Cell. 2025 Jan 13;43(1):49-68.e9. doi: 10.1016/j.ccell.2024.11.006. Epub 2024 Dec 5. Cancer Cell. 2025. PMID: 39642889
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma.
Villa M, Sharma GG, Malighetti F, Mauri M, Arosio G, Cordani N, Lobello C, Larose H, Pirola A, D'Aliberti D, Massimino L, Criscuolo L, Pagani L, Chinello C, Mastini C, Fontana D, Bombelli S, Meneveri R, Lovisa F, Mussolin L, Janikova A, Pospíšilová Š, Turner SD, Inghirami G, Magni F, Urso M, Pagni F, Ramazzotti D, Piazza R, Chiarle R, Gambacorti-Passerini C, Mologni L. Villa M, et al. Among authors: inghirami g. Br J Cancer. 2024 Dec;131(11):1781-1795. doi: 10.1038/s41416-024-02881-7. Epub 2024 Oct 30. Br J Cancer. 2024. PMID: 39478125 Free PMC article.
The interplay of mutagenesis and ecDNA shapes urothelial cancer evolution.
Nguyen DD, Hooper WF, Liu W, Chu TR, Geiger H, Shelton JM, Shah M, Goldstein ZR, Winterkorn L, Helland A, Sigouros M, Manohar J, Moyer J, Al Assaad M, Semaan A, Cohen S, Madorsky Rowdo F, Wilkes D, Osman M, Singh RR, Sboner A, Valentine HL, Abbosh P, Tagawa ST, Nanus DM, Nauseef JT, Sternberg CN, Molina AM, Scherr D, Inghirami G, Mosquera JM, Elemento O, Robine N, Faltas BM. Nguyen DD, et al. Among authors: inghirami g. Nature. 2024 Nov;635(8037):219-228. doi: 10.1038/s41586-024-07955-3. Epub 2024 Oct 9. Nature. 2024. PMID: 39385020 Free PMC article.
Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma: a LEO cohort study analysis.
Abro B, Maurer MJ, Habermann TM, Burack WR, Chapman JR, Cohen JB, Friedberg JW, Inghirami G, Kahl BS, Larson MC, Link BK, Lossos IS, Martin P, McDonnell TJ, Nastoupil LJ, Riska SM, Syrbu S, Vega F, Vij KR, Flowers CR, Cerhan JR, Jaye DL, Feldman AL. Abro B, et al. Among authors: inghirami g. Blood. 2024 Nov 7;144(19):2063-2066. doi: 10.1182/blood.2024025681. Blood. 2024. PMID: 39255410
New insights into the biology of T-cell lymphomas.
Iqbal J, Inghirami G, Chan WC. Iqbal J, et al. Among authors: inghirami g. Blood. 2024 Oct 31;144(18):1873-1886. doi: 10.1182/blood.2023021787. Blood. 2024. PMID: 39213420 Review.
333 results